Bayer

Bayer initiates Phase II study of investigational GIRK4 inhibitor in patients with atrial fibrillation

09 Sep 2026

Bayer advances combined seed and crop protection pipeline and enters phase of blockbuster launches

09 Sep 2026

Phase III REVEAL Study with Investigational PET Radiotracer Iodine 124 Evuzamitide Presented as Late-Breaker at ESC 2026

31 Aug 2026

Articles tagged with '2025-06-zoom-call' | Bayer

31 Aug 2026

Finerenone slowed kidney function decline and reduced kidney-cardiovascular risk versus placebo in patients with hypertensive nephropathy

31 Aug 2026

AskBio Presents Baseline Characteristics from Phase 2 Heart Failure Gene Therapy Trial of Umiposgene Parvec (AB-1002) at European Society of Cardiology Congress

31 Aug 2026

Bayer submits application in Japan for expanded use of Kerendia in chronic kidney disease therapeutic area

31 Aug 2026

Bayer’s sevabertinib approved in Japan for patients with HER2-mutant non-small cell lung cancer

24 Aug 2026

Aflibercept 8 mg application for macular edema following retinal vein occlusion accepted for review in China

13 Aug 2026

Bayer AG Second Quarter 2026 Results and Media Update

04 Aug 2026

View details about the software product Informachine News Trackers